Exelixis (EXEL) Balance Sheet

Click line-items for a historical chart and %

ASSETS
Cash and cash equivalents	129.83M
Marketable securities
Other receivables
Prepaid expenses and other current assets
Total current assets	353.38M
Restricted cash and investments	4.15M
Long-term investments	51.73M
Property and equipment, net	1.98M
Goodwill	63.68M
Other assets	2.21M
Total assets	477.14M
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	5.44M
Accrued compensation and benefits	10.31M
Accrued clinical trial liabilities
Other accrued liabilities	22.25M
Current portion of notes payable and bank obligations	80M
Current portion of convertible loans	27.5M
Current portion of restructuring
Deferred revenue	14.63M
Total current liabilities	192.8M
Long-term portion of notes payable and bank obligations	0
Long-term portion of convertible loans	288.56M
Long-term portion of restructuring
Other long-term liabilities	1.08M
Deferred revenue	180.84M
Total liabilities	663.27M
Commitments	0
Stockholders' deficit:
Common stock	230K
Additional paid-in-capital	1.85B
Accumulated other comprehensive income	129K
Accumulated deficit	-2.04B
Total stockholders' deficit	-186.13M
Total liabilities and stockholders' deficit	477.14M

Entities mentioned with EXEL